MDXH Competitors & Alternatives
Compare MDxHealth SA ADR with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$0.60
Tradestie Score
51
Market Cap
$231.40M
Revenue Growth
0.1%
Analyst Upside
+546.3%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$10.14
|
$1.13B | - | 60 | Compare |
|
CDNA
CareDx, Inc.
|
$22.31
|
$798.40M | - | 56 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.14
|
$719.31M | - | 60 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$20.39
|
$667.77M | - | 56 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$10.78
|
$612.76M | - | 55 | Compare |
|
NYXH
Nyxoah SA Ordinary Shares
|
$2.87
|
$185.47M | - | 50 | Compare |
|
MOLN
Molecular Partners AG American Depositary Shares
|
$4.03
|
$138.88M | - | 53 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.05
|
$112.28M | - | 55 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$1.01
|
$103.93M | - | 52 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$16.10
|
$61.36M | - | 56 | Compare |
More MDXH Analysis
Data updated: Jun 03, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry